← Open Payments lookup

AMANDA CURRY: Open Payments

NPI 1447594924 · ARNOLD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$952 in 45 payments from 18 companies in 2025. Trend: 2023 $753 · 2024 $754 · 2025 $952

Food & beverage: $952
CompanyPaymentsAmount
Novo Nordisk Inc7$171
PFIZER INC.5$105
ABBVIE INC.5$101
Lilly USA, LLC6$98
AstraZeneca Pharmaceuticals LP4$84
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$64
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$50
Astellas Pharma US Inc2$50
Boston Scientific Corporation1$45
Insulet Corporation1$33

Products named: MOUNJARO, VRAYLAR, Rybelsus, CAPLYTA, XIFAXAN, Veozah, Wegovy, NURTEC ODT.

Industry payments across MD — which companies pay providers there.